1. World Health Organization. The importance of pharmacovigilance-safety monitoring of medicinal products. Geneva: WHO; 2002.
2. Pharmacovigilance WH. Ensuring the safe use of medicines, WHO policy perspective of medicine. Geneva: WHO; 2004. p. 1222–39.
3. Supporting pharmacovigilance in developing Countries: the systems perspective. 1st ed. Arlington: Management Sciences for Health; 2009 [cited 8 Mar 2017]. http://apps.who.int/medicinedocs/documents/s18813en/s18813en.pdf .
4. Olsson S, Pal SN, Stergachis A, Couper M. Pharmacovigilance activities in 55 low-and-middle-income countries. Drug Saf. 2010;33(8):689–703.
5. Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol. 2015;8(4):449–60.